Edited by
Chantal Saunders
and
Beverley Moore ![]()
Other Industry News
The Indian Controller of Patents granted a Compulsory Licence to Natco Pharma Limited for Bayer's NEXAVAR sorafenib product.
About BLGThe content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.





